FDA Clearance Tracker · K252622
Male Latex Condom HA
Last checked: Nov 19, 2026Latest source record: May 4, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 4, 2026
Substantially Equivalent
Time to decision
258 days
Received Aug 19, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Abbreviated
Device class
Class II
The decision
- FDA number
- K252622
- Device name
- Male Latex Condom HA
- Applicant
- Okamoto USA, Inc.
- Applicant location
- Sandusky, OH
- Received
- Aug 19, 2025
- Decided
- May 4, 2026
- Decision
- Substantially Equivalent
- Submission type
- Abbreviated
Device type
- Device type
- Condom (HIS)
- Device class
- Class II
- Regulation
- 21 CFR 884.5300
- Specialty
- Obstetrics & Gynecology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code HIS. The earliest in FDA's data is K770412, decided Jun 17, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K252622
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Okamoto USA, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K243584 · Decided Feb 18, 2025 · 90 days after receipt
Device type: Condom (HIS) · Obstetrics & Gynecology
K203541 · Decided Feb 25, 2022 · 449 days after receipt
Device type: Condom, Synthetic (MOL) · Obstetrics & Gynecology
K192669 · Decided Jul 24, 2020 · 303 days after receipt
Device type: Condom (HIS) · Obstetrics & Gynecology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.